nilla, Author at European Medical Journal - Page 4 of 20

Chetak Buaria

Powering the new commercial model

Tune in to the next episode of the GOLD podcast to hear the team’s latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry’s evolving commercial model.

EMJ

EMJ Launches Cutting-Edge Careers Site

The Recruitment Team are thrilled to announce the launch of our brand new careers site, powered by the cutting-edge Applicant Tracking System (ATS), TeamTailor. The new platform aims to attract top talent and nurture a community of Gold Medal Winners.

Season 4 highlights: GOLD Medal Moments

The GOLD team are delighted to announce that Season 5 of the GOLD Podcast is going to be returning on 6 June!

UK unveils new health security strategy

The UK Health Security Agency launched its 10-year science strategy on 16 May 2023, detailing plans to protect UK from present and future health threats.

Raising women’s health up the agenda

This week (14-16 May) is National Women’s Health Week in the US. Read what the industry can do to close the gender health gap.

EMJ has been recognized as a Sunday Times Best Place to Work, Reinforcing Commitment to our Values and Gold Medal Winning Culture

EMJ has been recognized as a Sunday Times Best Place to Work. This recognition underscores EMJ’s dedication to creating an exceptional work environment that fosters personal growth, embodies strong values, and strives for excellence in everything it does.

5 minutes with Lance Hill, CEO, Within3

Lance Hill, CEO of Within3, talks to GOLD about the challenge of creating a market for their product and his personal and professional measures of success.

5 minutes with Marcel Gehrung, CEO and Co-Founder, Cyted

Marcel Gehrung, CEO and Co-Founder, Cyted, talks to Jade Williams about the greatest challenges facing his company.

Spoonful of technology: April 2023

GOLD reviews the top stories in health technology from the past few months, highlighting four innovative examples of how tech is changing treatment landscapes and patient experiences today.

UK generics body wants in on VPAS talks

The BGMA has launched legal action over the decision to only grant it ‘observer’ status in the upcoming VPAS negotiations. Read more.